Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019-11-01
|
| coleção: | Neurobiology of Stress |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2352289519300487 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|